Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Burzynski Research Institute Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for certified medical advice, visits or treatment by using a real doctor. We aren't doctors. Always confer with your physician on Burzynski Research Institute clinical studies. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Burzynski Research Institute Clinical research trials and Burzynski Research Institute health trials take place in hundreds of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectiveness of new does drugs. The aim of the studies / projects is to solve certain human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations like Burzynski Research Institute to discover remedies for all varieties of conditions. Burzynski Research Institute Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the masses. Many times the human subjects undergo professional assistance for without cost, and occasionally they are paid for their time. Occasionally there is a cost for a Burzynski Research Institute clinical trial. Human subjects often recieve the best healthcare possible for their condition. Hazards are a reality, however, and might include more or frequent dr. calls, medical risks (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Sponsors > Burzynski Research Institute Clinical Trials

Burzynski Research Institute Clinical Trials



Antineoplaston Therapy in Treating Children With Brain Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Colon Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Ependymoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Meningioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory High-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Condition: burzynski_research_institute_clinical_trials.html
Burzynski Research Institute



Burzynski Research Institute Clinical Trials
Modify your Search

Other "B" Clinical Trials Sponsors:

Baker Norton Pharmaceuticals
Baptist Hospital Of Miami
Barbara Ann Karmanos Cancer Institute
Barr Laboratories
Barrett Cancer Center
Bayer Corporation
Baylor College Of Medicine
Baylor University
Beckman Research Institute
Berlex Laboratories
Beth Israel Deaconess Medical Center
Biocodex
Biocryst Pharmaceuticals
Biocure Medical
Biogen Idec
Bioheart, Inc.
Biomarin Pharmaceutical
Biomeasure Inc, Ipsen Group
Biomedicines
Biomira Inc.
Bionumerik Pharmaceuticals, Inc.
Blood And Marrow Transplant Clinical Trials Network
Blumenthal Cancer Center At Carolinas Medical Center
Boehringer Ingelheim Pharmaceuticals
Boston Medical Center
Boston University School Of Medicine
Breast International Group
Brigham And Women's Hospital
Bristol-Myers Squibb
British Association Of Surgical Oncology: Breast Group
British Biotech Pharmaceuticals
British Columbia Cancer Agency
British National Lymphoma Investigation
British Thoracic Society
Burroughs Wellcome
Burzynski Research Institute


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103